TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Klebsiella pneumoniae subsp. pneumoniae (strain AT...)
Forge Therapeutics
US Patent
Forge Therapeutics
US Patent
Affinity DataIC50: 1nMAssay Description:LpxC inhibition assays were performed using liquid chromatography with tandem mass spectrometry. Assays were performed, in duplicate, in opaque, 96-w...More data for this Ligand-Target Pair
TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Klebsiella pneumoniae subsp. pneumoniae (strain AT...)
Forge Therapeutics
US Patent
Forge Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:LpxC inhibition assays were performed using liquid chromatography with tandem mass spectrometry. Assays were performed, in duplicate, in opaque, 96-w...More data for this Ligand-Target Pair
TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Klebsiella pneumoniae subsp. pneumoniae (strain AT...)
Forge Therapeutics
US Patent
Forge Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:LpxC inhibition assays were performed using liquid chromatography with tandem mass spectrometry. Assays were performed, in duplicate, in opaque, 96-w...More data for this Ligand-Target Pair
